维普期刊资源整合服务平台（V6.5）

159篇 您的检索式：作者名="Esken"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Matrix metalloproteinase inhibitors:current developments and future perspectives 显示文摘	Hoekstra R Eskens FA	2001	Oncologist2001，6，：	1
2	Matrix Metalloproteinase Inhibitors: Current Developments and Future Perspectives显示文摘	Hoekstra R Eskens F Verweij J	2001	The Oncologist2001，6，5：	1
3	Phase Ⅱ study of biweekly administration of paclitaxel and cisplatin in patients with advanced esophageal cancer显示文摘	Polee MB Eskens FA Burg ME	2002	Br Cancer2002，86，5：	1
4	Phase Ⅱ study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus显示文摘	Polee MB Tilanus HW Eskens FA	2003	Ann Oncol2003，14，8：	1
5	Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide,a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumors显示文摘	Eskens FA Dumez H Hoekstra R	2003	Eur J Canceer2003，39，7：	1
6	Phase Ⅰ and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974),a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours显示文摘	ESKENS FA DUMEZ H HOEKSTRA R	2003	Eur J Cancer2003，39，7：	1
7	Pathologic-anatomical changes in newborn goats caused by an intrauterine Schmallenberg virus infection显示文摘	Wagner H Eskens U Nesseler A	2014	Berl Munch Tierarztl Wochenschr2014，127，34：	1
8	PhaseⅡstudy of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus显示文摘	Polee MB Tilanus HW Eskens FA	2003	Ann Oncol2003，14，8：	1
9	First - line treament with oxaliplatin and capecitabine in pa- tients with advanced or metastatic oesophageal cancer:a phase Ⅱ study显示文摘	Van Meeten Eskens FA Van Gameren EC	2007	Br J Cancer2007，96，9：	1
10	Phase Ⅱ study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer显示文摘	Polee MB Eskens FA van der Burg ME	2002	Br J Cancer2002，86，5：	1
11	Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the e-sophagus显示文摘	Polee MB Tilanus HW Eskens FALM	2003	Annals of Oncology2003，14，8：	1
12	Angiogenesis inhibitors in clinical development; Where are we now and where are we going 显示文摘	Eskens F	2004	British J Cancer2004，90，1：	1
13	Phase I and Pharmacologic Study of PK1166,an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor,in Patients with Advanced Solid Malignancie显示文摘	Hoekstra R Dumez H Eskens F A	2005	Clin Cancer Res2005，11，19：	1
14	Matrix Metalloproteinase Inhibitors:Current Developments and Future Perspectives显示文摘	HOEKSTRA R ESKENS F VERWEIJ J	2001	The Oncologist2001，6，：	1
15	Phase I and pharmacokinet- ic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974),a novel inhibitor of the integrins al- phavbeta3 and alphavbeta5 in patients with advanced solid tu- mours显示文摘	Eskens FA Dumez H Hoekstra R	2003	Eur J Cancer2003，39，7：	1
16	Phase Ⅱ study of hi-weekly administration of paclitaxel and cisplatin in patients with advanced esophageal cancer显示文摘	Polee MB Eskens FA Van der Burg ME	2002	Br J Cancer2002，86，5：	1
17	Angiogenesis inhibitors in clinical development: where are we now and where are we going? 显示文摘	Eskens F	2004	Br J Cancer2004，90，1：	1
18	Pharmacologic study of PKI-166, an epidermal growth factor recap receptor tyrosine kinase inhibitor, inpatients with advanced solid malignancies显示文摘	Floekstra R Dumez H Eskens FA	2005	Clin Cancer Res2005，11，19：	1
19	Angiogenesis inhibitors in clinical development: whereare we now and where are we going显示文摘	Eskens FA	2004	Br J Cancer2004，90，1：	1
20	Predicting continued dizziness after an acute peripheral vestibular disorder 显示文摘	Heinrichs N Edler C Eskens S	2007	Psychosom Med2007，69，7：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示